Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effects
- 1 May 2007
- journal article
- case report
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 51 (5) , 640-643
- https://doi.org/10.1111/j.1399-6576.2007.01284.x
Abstract
Factor XI deficiency is a rare, hereditary bleeding disorder associated with a trauma-related bleeding tendency, caused by insufficient generation of the thrombin activatable fibrinolysis inhibitor (TAFI) evoking increased fibrinolysis. We present the case of a five year old girl with homozygote, severe factor XI deficiency presenting for surgery on two occasions. Modified thrombelastography (ROTEM) was used to assess effects of factor XI deficiency on coagulation, endogenous fibrinolysis, and potential effects of tranexamic acid, aprotinin and recombinant, activated Factor VII in an in vitro model of hyperfibrinolysis. According to our data and in consideration of the mechanisms of factor XI deficiency we decided on prophylactic use of tranexamic acid.Keywords
This publication has 10 references indexed in Scilit:
- Treatment of factor XI inhibitor using recombinant activated factor VIIaHaemophilia, 2005
- Thrombin Activatable Fibrinolysis Inhibitor (TAFI) at the Interface between Coagulation and FibrinolysisPathophysiology of Haemostasis and Thrombosis, 2003
- Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiencyHaemophilia, 2002
- Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia ABlood, 2002
- Management of fulminant fibrinolysis during abdominal aortic surgeryJournal of Cardiothoracic and Vascular Anesthesia, 2001
- The use of recombinant factor VIIa (NovoSeven®) in a patient with a factor XI deficiency and a circulating anticoagulantBlood Coagulation & Fibrinolysis, 2001
- Case 8: Isolated prolongation of the activated partial thromboplastin time in a patient with a bleeding history – severe Factor XI deficiencyTherapeutische Umschau, 1999
- Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysisBlood, 1995
- Thrombogenic potential of factor XI concentrateThe Lancet, 1994
- Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patientsBlood, 1994